Rapport Therapeutics, Inc. Common Stock Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 20.0M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | 227K | 265K | 256K | 0 | 244K | 260K | 219K | 208K |
| Gross Profit | 19.8M | -265K | -256K | 0 | -244K | -260K | -219K | -208K |
| R&D Expenses | 32.7M | 30.3M | 22.3M | 22.7M | 19.6M | 17.2M | 15.5M | 15.7M |
| Operating Expenses | 44.0M | 38.2M | 30.0M | 29.5M | 27.1M | 23.5M | 21.6M | 20.6M |
| Operating Income | -24.2M | -38.5M | -30.0M | -29.5M | -27.1M | -23.5M | -21.6M | -20.8M |
| Other Income / Gains | 4.4M | 4.7M | 3.1M | 2.8M | 3.0M | 3.5M | 4.1M | 2.7M |
| Net Income | -19.9M | -33.8M | -26.9M | -26.7M | -24.1M | -20.0M | -17.5M | -18.1M |
| EPS (Diluted) | -0.42 | -0.72 | -0.71 | -0.75 | -0.68 | -0.57 | -0.50 | -0.50 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.989 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General And Administrative Expenses | 11.5M | 8.3M | 7.7M | 6.8M | 7.5M | 6.3M | 6.1M | 5.1M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -208K |
| Selling General And Administrative Expenses | 11.5M | 8.3M | 7.7M | 6.8M | 7.5M | 6.3M | 6.1M | 4.9M |
| Other Expenses | -227K | -265K | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 44.2M | 38.5M | 30.0M | 29.5M | 27.1M | 23.5M | 21.6M | 20.8M |
| Interest Income | 4.4M | 4.7M | 3.1M | 2.8M | 3.0M | 3.5M | 4.1M | 2.7M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 227K | 265K | 256K | 252K | 244K | 260K | 219K | 208K |
| Ebitda | -24.0M | -38.2M | -26.7M | -29.2M | -26.9M | -23.3M | -21.4M | -20.6M |
| Ebitdaratio | -1.199 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income Ratio | -1.211 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | -19.9M | -33.8M | -26.9M | -26.7M | -24.1M | -20.0M | -17.5M | -18.1M |
| Income Before Tax Ratio | -0.993 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | -0.993 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Epsdiluted | -0.42 | -0.72 | -0.71 | -0.75 | -0.68 | -0.57 | -0.50 | -0.50 |
| Weighted Average Shs Out | 47.2M | 47.0M | 37.9M | 35.4M | 19.3M | 19.3M | 19.2M | 20.1M |
| Weighted Average Shs Out Dil | 47.2M | 47.0M | 37.9M | 35.4M | 19.3M | 19.3M | 19.2M | 20.1M |